Effects of Rapamycin Combined with Low Dose Prednisone in Patients with Chronic Immune Thrombocytopenia

Table 3

Comparison of prognostic factors between sustained responsive group and nonsustained responsive group.

Clinical and laboratoristic prognostic factors	The SR group	The non-SR group	𝑃
Patients’ number	28	25
Males/females	12/16	6/19	0.154
Mean age, years	32 (14–58)	36 (14–65)	0.302
Mean duration, years	3.07 (2–6)	2.88 (2–5)	0.504
Mean baseline Plt, ×10^9/L	22.96 (11–31)	21.96 (11–35)	0.581
Mean MEG count in bone marrow slide	107 (34–213)	91 (34–147)	0.088
Mean numbers of previous treatments	3 (2–4)	3 (2–5)	0.584

The SR/non-SR group included patients with SR/non-SR in both groups; MEG: megakaryocyte; Plt: platelet.